Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Structure Therapeutics Inc ADR (NASDAQ: GPCR) closed at $18.73 down -8.03% from its previous closing price of $20.36. In other words, the price has decreased by -$8.03 from its previous closing price. On the day, 0.73 million shares were traded. GPCR stock price reached its highest trading level at $20.605 during the session, while it also had its lowest trading level at $18.72.
Ratios:
For a deeper understanding of Structure Therapeutics Inc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.29 and its Current Ratio is at 23.29. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on May 02, 2025, initiated with a Buy rating and assigned the stock a target price of $60.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $50.Stifel initiated its Buy rating on January 08, 2025, with a $50 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GPCR now has a Market Capitalization of 1077664256 and an Enterprise Value of 2750641664.
Stock Price History:
The Beta on a monthly basis for GPCR is -1.97, which has changed by -0.5247399 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, GPCR has reached a high of $47.48, while it has fallen to a 52-week low of $13.22. The 50-Day Moving Average of the stock is -19.04%, while the 200-Day Moving Average is calculated to be -33.07%.
Shares Statistics:
For the past three months, GPCR has traded an average of 923.48K shares per day and 677840 over the past ten days. A total of 57.54M shares are outstanding, with a floating share count of 54.69M. Insiders hold about 4.94% of the company’s shares, while institutions hold 93.70% stake in the company. Shares short for GPCR as of 1749772800 were 8273171 with a Short Ratio of 8.96, compared to 1747267200 on 9318875. Therefore, it implies a Short% of Shares Outstanding of 8273171 and a Short% of Float of 20.76.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Structure Therapeutics Inc ADR (GPCR) reflects the collective analysis of 8.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.27 and low estimates of -$1.13.
Analysts are recommending an EPS of between $1.78 and -$4.14 for the fiscal current year, implying an average EPS of -$1.11. EPS for the following year is -$1.89, with 9.0 analysts recommending between -$1.1 and -$5.65.
